RIGEL PHARMACEUTICALS INC — Director's Dealing 2018

Oct 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2018-10-12

Reporting Person: Cabatuan Nelson (Principal Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-10-12	Common Stock	S	10000	$3.12	Disposed	58	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 5, 2018.

F2: Includes Reporting Person's purchases of 5,000 shares on December 29, 2017 and 5,000 shares on June 26, 2018 under the Issuer's Employee Stock Purchase Plan.